Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Color blindness among multiple sclerosis patients in Isfahan.
High spatial and angular resolution diffusion-weighted imaging reveals forniceal damage related to memory impairment.
Treatment patterns in multiple sclerosis: administrative claims analysis over 10 years.
Experience with Fingolimod in Clinical Practice.
Brain Metabolite Changes in Subcortical Regions After Exposure to Cuprizone for 6 Weeks: Potential Implications for Schizophrenia.
Neurochemistry of Hypomyelination Investigated with MR Spectroscopy.
Quantifying progression of multiple sclerosis via classification of depth videos.
Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
Longitudinal changes in self-reported walking ability in multiple sclerosis.
Systematic Review: The effectiveness of interventions to reduce falls and improve balance in adults with multiple sclerosis.
Brain Plasticity Effects of Neuromodulation Against Multiple Sclerosis Fatigue.
An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
MRI unsampling using feature-based non-local means approach.
Connexin astrocytopathy and novel therapeutic strategy targeting connexin hemichannels in demyelinating disease.
LSN MS guidelines for the management of multiple sclerosis.
The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment.
Chondroitin sulfate β-1,4-N-acetylgalactosaminyltransferase-1 (ChGN-1) polymorphism: Association with progression of multiple sclerosis.
Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE).
High-mobility group box 1 in multiple sclerosis.
Vitamin D: Health Panacea or false Prophet?
Soluble axoplasm enriched from injured CNS axons reveals the early modulation of the actin cytoskeleton.
LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis.
The co-occurrence of pain and depression in adults with multiple sclerosis.
Treatment with interferon beta for multiple sclerosis.
Saffold Virus Type 3 (SAFV-3) Persists in HeLa Cells.

Pages